Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Pharmacodynamic effects of xemilofiban in cirrhotics

March 18, 1997

Taisho claims orally active antiplatelet agents

March 18, 1997

NM-702 enters phase II trials

March 14, 1997

Boehringer Mannheim reports new antiplatelet agents

March 13, 1997

Agrylin granted priority review in Canada

March 7, 1997

Thrombin inhibitors disclosed by Astra

March 6, 1997

FDA advisory committee decision regarding Integrilin

March 4, 1997

Fibrinogen antagonists disclosed by Terumo

March 3, 1997

Abciximab and acute profound thrombocytopenia

Feb. 28, 1997

Antithrombotics from Fuji Yakuhin

Feb. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.